GL-V9
GL-V9 inhibits proliferation of HepG2 cell (IC50 is 35.2 μM) through induction of apoptosis and cell cycle arrest at G2/M phase. GL-V9 regulates mitochondrial membrane potential and increases the production of intracellular reactive oxygen species. GL-V9 inhibits the pentose phosphate pathway (PPP), enhances fatty acid oxidation (FAO) through activation of AMPK, and thus inhibits the metastasis of cancer cells. GL-V9 exhibits antitumor efficacy in mouse model[1][2].
Product Specifications
CAS Number
1178583-19-1
UNSPSC
12352005
Target
AMPK; Apoptosis; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gl-v9.html
Smiles
O=C1C=C(C2=CC=CC=C2)OC3=C(OC)C(OCCCCN4CCCC4)=CC(O)=C13
Molecular Formula
C24H27NO5
Molecular Weight
409.47
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Geobacter lovleyi Transcription elongation factor GreA (greA)
Recombinant Geobacter lovleyi Transcription elongation factor GreA (greA)
Recombinant Geobacter lovleyi Transcription elongation factor GreA (greA)
Recombinant Geobacter lovleyi Transcription elongation factor GreA (greA)
Recombinant Geobacter lovleyi Transcription elongation factor GreA (greA)